Background: Allogeneic hematopoietic cell transplantation is indicated for refractory
hematologic cancer and some nonmalignant disorders. Survival is limited by recurrent …

Introduction: Progress in allogeneic hematopoietic stem cell transplantation (HSCT)
procedures has been associated with improved survival in HSCT recipients. However, they …

Approximately 2,500 pediatric hematopoietic cell transplants (HCTs), most of which are
allogeneic, are performed annually in the United States for life-threatening malignant and …

Hematopoietic stem cell transplantation (HSCT) is increasingly being used for a variety of
malignant and nonmalignant conditions. With improvements in donor selection and …

Our current knowledge of idiopathic pneumonia syndrome (IPS) predates improved
specificity in the diagnosis of IPS and advances in hematopoietic cell transplantation (HCT) …

Noninfectious pulmonary toxicity (NPT), a significant complication of allogeneic
hematopoietic cell transplantation (alloHCT), includes idiopathic pneumonia syndrome …

Background Idiopathic pneumonia syndrome (IPS) is a non-infectious fatal complication
characterized by a massive infiltration of leukocytes in lungs and diffuse pulmonary injury …

Plasma biomarkers associated with respiratory failure (RF) following hematopoietic cell
transplantation (HCT) have not been identified. Therefore, we aimed to validate early (7 and …

Non-infectious pulmonary complications (NIPCs) following allogeneic hematopoietic stem
cell transplantation (HSCT) are relatively rare, but frequently fatal. This study investigated …

Noninfectious lung diseases contribute to nonrelapse mortality. They constitute a spectrum
of diseases that can affect the parenchyma, airways, or vascular pulmonary components and …